NDC 0024-0656 – Sarclisa
Isatuximab 500 mg/25mL · Injection, Solution, Concentrate · Intravenous
Product NDC0024-0656
Product details
- Brand name
- Sarclisa
- Generic name
- Isatuximab
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- BLA · BLA761113
- Marketed since
- March 2, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD38-directed Cytolytic Antibody
Active ingredients
- Isatuximab 500 mg/25mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0024-0656-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0024-0656-01) / 25 mL in 1 VIAL, SINGLE-DOSE | Mar 2, 2020 |
Other Sarclisa products
- 0024-0654 Isatuximab 100 mg/5mL · Injection, Solution, Concentrate · Sanofi-Aventis U.S. LLC